Navigation Links
Resverlogix Completes Dosing for ASSERT Trial
Date:5/12/2010

pare the dose and time response relationship for ApoA-I as well as to examine key reverse cholesterol markers involved with HDL functionality.

In related clinical news the parallel Phase 2 ASSURE trial for RVX-208, which announced its first site activation on February 25th, will be reassessing its enrollment procedure. Since the ASSERT trial provides us with data much faster than first anticipated, we can also now apply pertinent findings to the ASSURE trial. In order to expedite enrollment, while continuing our primary patient safety concerns, the ASSURE trial is being voluntarily halted on a temporary basis in order to modify enrollment procedures. "While the ASSERT trial set records for enrollment, the much more intricate ASSURE trial will not for the reason that the inclusion criteria is much more detailed and intensive. ASSURE currently requires a patient must have had a heart attack within the past four weeks. The patient is then required to voluntarily submit to having two invasive Intravascular Ultrasound (IVUS) both at the start and finish of the 90 day drug treatment period. We believe that we can enhance the enrollment procedure by modifying the inclusion criteria. One such option would be to include any patients sent to the Catheter Lab, thus greatly increasing the pool of patients that we would be able to draw from for enrolment in this trial. Patients will also now benefit from any added knowledge that we are about to gain from the successful completion of dosing in the ASSERT trial," stated Donald McCaffrey.

In other news today, Donald J. McCaffrey will be providing an updated corporate and clinical overview at 1:00 pm EDT. A slide presentation will be followed by a question and answer session regarding the impact of the early completion of the ASSERT trial and the enh
'/>"/>

SOURCE Resverlogix Corp.
Copyright©2010 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Resverlogix Presents Key Apo-Al/HDL Scientific Data at DALM
2. Resverlogix is Presenting at IAS HDL Workshop
3. Resverlogix Honoured with World Economic Forum Technology Pioneer Award
4. FDA Grants Resverlogix Approval to Commence a Phase 1 Clinical Trial for RVX-208
5. Resverlogix Share Option Extension
6. Resverlogix Notice of Conference Call & Webcast
7. /C O R R E C T I O N from Source -- Resverlogix Corp./
8. Industry Leaders Select Resverlogixs RVX-208
9. Resverlogixs Lead Drug Featured in Key Scientific Publication
10. Jan Gray Joins Resverlogix Board of Directors
11. Resverlogix Notice of Conference Call & Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... The paradigm of ‘one drug, one target’ ... help predict the adverse and therapeutic effects of a ... Computational Biology at the Genomics Laboratory, Covance, will discuss ... genomics when used as part of the QC process. ... sets to identify key clinical targets even in complex ...
(Date:5/17/2013)... WA (PRWEB) May 17, 2013 Tooth decay ... graders showing active signs of the disease. The World Health ... and nearly 100% of adults have cavities. What are the ... is showing a strong connection between the oral bacterial ... is this disease so rampant, yet it is also 100% ...
(Date:5/16/2013)... Zealand (PRWEB) May 16, 2013 In late ... invited to speak to doctors in China about Appearance ... and NZ, this was her first trip to lecture in ... Hart visited Guangzhou and Fuzhou, home to 12 and 7 ... China is very high at this point in time. As ...
(Date:5/16/2013)... PORTLAND, Ore. , May 16, 2013 /PRNewswire/ ... to many of the nation,s largest regional health ... the America,s Health Insurance Plans (AHIP) Institute 2013 ... and highlight survey results showing how health insurance ... planning for the consumer and marketplace demands for ...
Breaking Biology Technology:Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 2Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 3HealthSparq to Reveal New Healthcare Transparency Benchmark Study at AHIP Institute 2013 2HealthSparq to Reveal New Healthcare Transparency Benchmark Study at AHIP Institute 2013 3
... the H1N1 flu virus, could help to ease future vaccine ... with the flu virus. In a study published ... Breath Research , researchers have investigated an easy, non-invasive breath ... H1N1 strain. Research published last month claimed that ...
... 14, 2011 BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ... for BMN 673, a poly ADP-ribose polymerase (PARP) inhibitor, for ... 1/2 trial for BMN 673 for the treatment of patients ... ongoing. "We are excited to be at ...
... Quest Diagnostics (NYSE: DGX ), ... and services, and Genomic Vision, a biotechnology company dedicated ... a multi-year exclusive collaboration involving Genomic Vision,s proprietary ... terms of the agreement, Quest Diagnostics has exclusive ...
Cached Biology Technology:'Swine flu' breath test could reduce future vaccination shortages, research suggests 2BioMarin Initiates Phase 1 Trial for BMN 673 in Patients With Advanced Hematological Malignancies 2BioMarin Initiates Phase 1 Trial for BMN 673 in Patients With Advanced Hematological Malignancies 3Quest Diagnostics and Genomic Vision Form Strategic Collaboration to Develop Genome-based Laboratory Tests 2Quest Diagnostics and Genomic Vision Form Strategic Collaboration to Develop Genome-based Laboratory Tests 3Quest Diagnostics and Genomic Vision Form Strategic Collaboration to Develop Genome-based Laboratory Tests 4
(Date:5/16/2013)... shown a gene involved in neurodegenerative disease also plays ... circadian clock. , In a study of the ... Ataxin-2, keeps the clock responsible for sleeping and waking ... of the fruit fly,s sleep-wake cycle is disturbed, making ... fly. , The discovery is particularly interesting because ...
(Date:5/16/2013)... The endothelium, the cellular layer lining the body,s ... few hundred nanometers in thickness, this super-tenuous structure ... tissue compression to create a unique and highly ... partition tissues from the body,s circulatory system. , ... barrier must be physically breached to enable ...
(Date:5/16/2013)... sports players and athletes choose to wear the color ... published in Psychological Science , a journal of ... have to do with their testosterone levels. , The ... the University of Sunderland and colleagues, demonstrated that males ... task had higher testosterone levels than other males who ...
Breaking Biology News(10 mins):Gene involved in neurodegeneration keeps clock running 2Endothelium, heal thyself 2Endothelium, heal thyself 3Endothelium, heal thyself 4High-testosterone competitors more likely to choose red 2
... calling for levels of obesity among South Asians to be ... Leicester. A team from the University,s Departments of ... the point at which South Asians should be classed as ... in PLoS One , a journal of the Public ...
... Institute ( http://cmi.vt.edu/ ), a research center within ... has provided technical expertise for the world,s first ... Degradation (REDD) project to receive certification under the ... http://www.v-c-s.org/ ). The UN-REDD Programme ( http://www.un-redd.org/ ) ...
... a tasteless, colorless and odorless gas, is not only a ... beings. Found in the exhaust of vehicles and generators, CO ... lethal, poisoning the nervous system and heart. Now, ... University,s Department of Geography and the Human Environment has discovered ...
Cached Biology News:New research calls for lower limit to be set for South Asian obesity level 2First UN carbon offset project certified 2Carbon monoxide -- the silent calmer? 2
Bis-Acrylamide (bis) is a monomer used as a crosslinker with acrylamide to form polyacrylamide electrophoretic gels. This 2% bis solution is supplied as 500 ml....
... EnVision™ G|2 Doublestain System is a ... visualization kit. The kit is intended ... simultaneous detection of two different antigens ... compatible with suitably diluted rabbit and ...
AVOID FREEZE/THAW CYCLES. Recognizes the UCP-2 protein....
Rabbit Anti-Human Janus Kinase 2 (JAK2 Polyclonal Antibody Family: Protein Kinase Sub-Family: TYK2/JAK Applications: ELISA, Western Blot...
Biology Products: